Used ARTHROCARE Electrothermal Arthroscopy System For Sale – DOTmed Listing # Specifications: Year of Manufacture. YOM: Condition: Pre-owned. Good condition. The unit will be delivered exactly the way it is displayed on the accompanying photos. Dimensions: 62 x 48 x (H) cm / with opened table x 48 x (H) Condition: Pre-owned. Good condition. The unit will be delivered.
|Published (Last):||6 April 2011|
|PDF File Size:||18.67 Mb|
|ePub File Size:||11.48 Mb|
|Price:||Free* [*Free Regsitration Required]|
ArthroCare also became active on the acquisitions front in the early s. In addition, the company vacated its headquarters-manufacturing facility for a new Sunnyvale campus offering twice as much space. In addition, ArthroCare gained the distribution rights to a line of medical screws used in arthroscopy, thus helping the company to round out its product line in the United States. In addition to Sunnyvale, the company also maintains a campus in Austin, Texas, a manufacturing plant in Costa Rica, and an international office in Stockholm, Sweden.
Although the company had branched into a variety of fields, arthroscopic surgery continued to supply the bulk of sales.
ArthroCare System Arthroscopic Electrosurgery Electrosurgical Controller | eBay
In Arthroare received approval to use Coblation technology to remove tonsils, opening up yet another source of revenues. Based in Sunnyvale, California, ArthroCare Corporation is a medical device company, relying mostly on its patented Coblation technology. Instead they decided to look for surgical applications in which precision was a major selling point and settled on arthroscopic joint surgery.
After some investigation they realized that the radiofrequency energy they were using had ionized the electrolytes in the conductive fluid, and these ions in turn possessed enough energy to break down the molecules of the soft tissue, essentially dissolving the tissue without generating enough heat to burn surrounding areas.
Michael Baker is named president and CEO.
Because of the addition of Parallax’s technology, ArthroCare launched a concerted effort to market its spine surgery product lines around the world. Primary reasons 2000 the shortfall was the hiring of a sales force to free the company from its dependence on U.
It had to turn arthrocre the court system to protect the patent on its technology. As a result, when ArthroCare unveiled its first Coblation wands at an arthroscopy trade show in a crowd of surgeons circled the company’s booth. Although ArthroCare enjoyed rapid growth during the late s and into the s, it also faced challenges on a myriad of fronts.
In ArthroCare completed a pair of significant acquisitions.
About six months after Baker arthrocage over, ArthroCare forged a partnership with Boston Scientific to develop a Coblation system suitable for cardiac surgery. Coblation-based products use radiofrequency energy to dissolve soft tissue without burning, unlike other radiofrequency-based products, like lasers, that are heat-driven.
Previously, ArthroCare relied on suppliers who did subassembly in Mexico. ArthroCare received a patent on its Coblation technology in In ArthroCare had completed the development of a commercial product using Coblation technology.
Arthrocare System 2000 Timer
Sales continued to mount and new markets were beginning to open up, but to achieve the kind of growth its founders envisioned it was time to bring in a more seasoned executive to take the business to the next stage in its development.
The balance sheet also was adversely impacted by the unexpected write-off of inventory. It was apparent that this phenomenon held great promise, since it offered surgeons greater precision than could be found with traditional electrosurgical instruments, lasers, or even scalpels.
In it sued Ethicon Inc. It has found a ready market among surgeons using single-use ArthroWands repairing the knees and shoulders of athletes.
ArthroCare System 2000 Arthroscopic Electrosurgery Electrosurgical Controller
Although the partners were excited by the Coblation technology they had stumbled upon it could be used to clear a clogged artery without causing harm to surrounding tissue they began having second thoughts arthroczre trying to enter the highly competitive cardiac product field, requiring a great deal of seed money and years to gain FDA approval.
But an accidental discovery changed the direction their start-up company would take. The company announced that it would begin to spread out revenues starting with the first quarter ofbut what Forbes called the “day of reckoning” kept getting pushed back later into the year.
In early ArthroCare received FDA approval for its method of facial resurfacing, that is, wrinkle reducing. Thapliyal and Philip E.
The ArthroCare Sports Medicine unit is devoted arthrocar products used in arthroscopic joint surgery, the company’s first application for Coblation. The two sides settled in July with Ethicon agreeing to license some of ArthroCare’s technology.
Although tissue was clearly being removed, they could find no evidence of burned edges. To build on its direct sales efforts in the sports medicine field, it acquired Atlantech Medical Devices, Ltd. Chandler, Michele, “Sunnyvale, Calif.